Sign in

CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company

ABEONA THERAPEUTICS INC.

Sign in to watch
Ticker
ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
830221517
Phone
646-813-4701
Business address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
Former names
PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$296,397
in 5 filings

Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-16 Alland Leila Director Purchase +11,000 $4.71 $52K 82,857
2024-04-26 Charles Faith L. Director Purchase +7,550 $3.28 $25K 78,323
2024-04-25 Seshadri Vishwas Chief Executive Officer Purchase +10,000 $3.20 $32K 538,260
2024-04-25 O'Malley Brendan M. SVP, General Counsel Purchase +8,600 $3.24 $28K 188,718
2024-04-25 Vazzano Joseph Walter Chief Financial Officer Purchase +5,608 $3.14 $18K 233,868
2024-02-06 Seshadri Vishwas Chief Executive Officer Purchase +20,000 $4.39 $88K 528,260
2023-09-27 Seshadri Vishwas Chief Executive Officer Purchase +20,000 $4.07 $81K 521,731
2023-09-19 Vazzano Joseph Walter Chief Financial Officer Purchase +14 $3.70 $52 235,193
2023-09-19 Vazzano Joseph Walter Chief Financial Officer Purchase +2,986 $3.82 $11K 238,179
2023-09-18 O'Malley Brendan M. SVP, General Counsel Purchase +3,000 $3.80 $11K 187,421
2022-12-09 O'Malley Brendan M. SVP, General Counsel Purchase +5,869 $3.13 $18K 93,830
2022-11-18 Vazzano Joseph Walter Chief Financial Officer Purchase +2,500 $4.00 $10K 95,250
2022-11-18 O'Malley Brendan M. SVP, General Counsel Purchase +7,500 $3.99 $30K 87,961

Page 1 of 1 · 13 trades